Inventor
PODESTO DANTE D
US6 patents
Patents
6 patentsUS10028960B2Jul 24, 2018
Pyrimidine compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC18 citations93
US9725470B2Aug 8, 2017
Substituted naphthyridines as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC27 citations93
US11780852B2Oct 10, 2023
Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
THERAVANCE BIOPHARMA R&D IP LLC3 citations83
US10947254B2Mar 16, 2021
Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
THERAVANCE BIOPHARMA R&D IP LLC3 citations83
US11110095B2Sep 7, 2021
Pyrimidine compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC3 citations72
US12358931B2Jul 15, 2025
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC0 citations62